FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092243329> ?p ?o ?g. }

• W3092243329 abstract "To evaluate factors related to liver graft survival with a focus on immunosuppressive schemes based on calcineurin inhibitors (tacrolimus or cyclosporine).This study was carried out through an open cohort constructed by deterministic and probabilistic matching through three databases of the SUS with assessment of liver graft survival from 2000 to 2015 in Brazil. From this first cohort, a second cohort was constructed by pairing 1: 1 to more precisely assess the effect of the immunosuppressive scheme on graft survival. The Kaplan-Meier method and was used to estimate the probability of survival. Cox's model of proportional risks was used to assess factors related to graft loss.We found 12,687 patients in the Full cohort and 470 patients in the Matched cohort. The overall graft survival rates at 1, 5, 10, and 16 years were 72.6, 63.3, 52.8, and 45.3%, respectively. Patients younger had a longer graft survival than older ones. In the Full cohort, male patients had a higher survival rate than female ones. Therapeutic schemes based on tacrolimus were more prevalent and had a better survival rate when compared to schemes that used cyclosporine. Tacrolimus without association with antiproliferative agents or rapamycin inhibitors was the therapeutic scheme associated with greater survival rate in both cohorts (HR = 0.81, 95% CI = 0.72-0.91), (HR = 0.50, 95% CI = 0.30-0.85). In addition, white-skinned patients had longer survival rate in both cohorts (HR = 0.55, 95% CI = 0.50-0.61 and HR = 0.50, 95% CI = 0.34-0.75). On the other hand, patients who a greater time ratio without using an immunosuppressant had lower graft survival rate (HR = 6.46, 95% CI = 5.05-8.27 and HR = 6.57, 95% CI = 2.66-16.22).This 16-year cohort showed that the older age and the greater time ratio without using an immunosuppressant are risk factors for liver graft loss. White-skinned patients and tacrolimus-based regimens, especially tacrolimus without other immunosuppressants, are factors of better prognosis to the graft." @default.
• W3092243329 created "2020-10-15" @default.
• W3092243329 creator A5005814129 @default.
• W3092243329 creator A5006484047 @default.
• W3092243329 creator A5015244722 @default.
• W3092243329 creator A5022585867 @default.
• W3092243329 creator A5023743627 @default.
• W3092243329 creator A5050696695 @default.
• W3092243329 creator A5064829722 @default.
• W3092243329 creator A5072359942 @default.
• W3092243329 creator A5073660015 @default.
• W3092243329 creator A5088210795 @default.
• W3092243329 date "2020-10-06" @default.
• W3092243329 modified "2023-10-14" @default.
• W3092243329 title "Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies" @default.
• W3092243329 cites W1577923989 @default.
• W3092243329 cites W1665091962 @default.
• W3092243329 cites W1967291837 @default.
• W3092243329 cites W2003832151 @default.
• W3092243329 cites W2011540476 @default.
• W3092243329 cites W2014501030 @default.
• W3092243329 cites W2020329640 @default.
• W3092243329 cites W2021814155 @default.
• W3092243329 cites W2025458886 @default.
• W3092243329 cites W2026646977 @default.
• W3092243329 cites W2039224714 @default.
• W3092243329 cites W2043969724 @default.
• W3092243329 cites W2049259235 @default.
• W3092243329 cites W2061818211 @default.
• W3092243329 cites W2071007793 @default.
• W3092243329 cites W2095561092 @default.
• W3092243329 cites W2111247982 @default.
• W3092243329 cites W2117601892 @default.
• W3092243329 cites W2127746188 @default.
• W3092243329 cites W2144926427 @default.
• W3092243329 cites W2161050084 @default.
• W3092243329 cites W2283978743 @default.
• W3092243329 cites W2346278583 @default.
• W3092243329 cites W2384349701 @default.
• W3092243329 cites W2514916723 @default.
• W3092243329 cites W2560881956 @default.
• W3092243329 cites W2883919738 @default.
• W3092243329 cites W2894092623 @default.
• W3092243329 cites W2901781294 @default.
• W3092243329 cites W2913550407 @default.
• W3092243329 cites W4242733376 @default.
• W3092243329 doi "https://doi.org/10.3389/fphar.2020.572043" @default.
• W3092243329 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7573511" @default.
• W3092243329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33123009" @default.
• W3092243329 hasPublicationYear "2020" @default.
• W3092243329 type Work @default.
• W3092243329 sameAs 3092243329 @default.
• W3092243329 citedByCount "1" @default.
• W3092243329 countsByYear W30922433292023 @default.
• W3092243329 crossrefType "journal-article" @default.
• W3092243329 hasAuthorship W3092243329A5005814129 @default.
• W3092243329 hasAuthorship W3092243329A5006484047 @default.
• W3092243329 hasAuthorship W3092243329A5015244722 @default.
• W3092243329 hasAuthorship W3092243329A5022585867 @default.
• W3092243329 hasAuthorship W3092243329A5023743627 @default.
• W3092243329 hasAuthorship W3092243329A5050696695 @default.
• W3092243329 hasAuthorship W3092243329A5064829722 @default.
• W3092243329 hasAuthorship W3092243329A5072359942 @default.
• W3092243329 hasAuthorship W3092243329A5073660015 @default.
• W3092243329 hasAuthorship W3092243329A5088210795 @default.
• W3092243329 hasBestOaLocation W30922433293 @default.
• W3092243329 hasConcept C10515644 @default.
• W3092243329 hasConcept C126322002 @default.
• W3092243329 hasConcept C128057223 @default.
• W3092243329 hasConcept C141071460 @default.
• W3092243329 hasConcept C201903717 @default.
• W3092243329 hasConcept C2776283816 @default.
• W3092243329 hasConcept C2779609443 @default.
• W3092243329 hasConcept C2780252810 @default.
• W3092243329 hasConcept C2909675724 @default.
• W3092243329 hasConcept C2911091166 @default.
• W3092243329 hasConcept C50382708 @default.
• W3092243329 hasConcept C71924100 @default.
• W3092243329 hasConcept C72563966 @default.
• W3092243329 hasConceptScore W3092243329C10515644 @default.
• W3092243329 hasConceptScore W3092243329C126322002 @default.
• W3092243329 hasConceptScore W3092243329C128057223 @default.
• W3092243329 hasConceptScore W3092243329C141071460 @default.
• W3092243329 hasConceptScore W3092243329C201903717 @default.
• W3092243329 hasConceptScore W3092243329C2776283816 @default.
• W3092243329 hasConceptScore W3092243329C2779609443 @default.
• W3092243329 hasConceptScore W3092243329C2780252810 @default.
• W3092243329 hasConceptScore W3092243329C2909675724 @default.
• W3092243329 hasConceptScore W3092243329C2911091166 @default.
• W3092243329 hasConceptScore W3092243329C50382708 @default.
• W3092243329 hasConceptScore W3092243329C71924100 @default.
• W3092243329 hasConceptScore W3092243329C72563966 @default.
• W3092243329 hasLocation W30922433291 @default.
• W3092243329 hasLocation W30922433292 @default.
• W3092243329 hasLocation W30922433293 @default.
• W3092243329 hasLocation W30922433294 @default.
• W3092243329 hasOpenAccess W3092243329 @default.
• W3092243329 hasPrimaryLocation W30922433291 @default.
• W3092243329 hasRelatedWork W2025321012 @default.
• W3092243329 hasRelatedWork W2039925961 @default.

• next